Novel Therapeutics for Fibrolamellar Carcinoma
Abstract
In Project 3, we have made substantial progress despite a slow-down of research activities due to the ongoing COVID-19 pandemic. We have found that immune cells in FLC are biased towards being in the stromal bands or peritumoral interface. We have found that PD-1 and IL-10 blockade each have some effects against FLC slice cultures in vitro. We are presently completing a manuscript detailing our findings from the first year of the project.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2020
- Accession Number
- AD1117697
Entities
People
- Venu G Pillarisetty
Organizations
- University of Washington